OSR Holdings PE Ratio 2023-2025 | OSRH
Current and historical p/e ratio for OSR Holdings (OSRH) from 2023 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. OSR Holdings PE ratio as of July 03, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| OSR Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-03 | 1.35 | 0.00 | |
| 2025-03-31 | 1.88 | $-1.04 | 0.00 |
| 2024-12-31 | 11.53 | 0 | 0.00 |
| 2024-09-30 | 10.89 | 0 | 0.00 |
| 2024-06-30 | 10.76 | 0 | 0.00 |
| 2024-03-31 | 10.66 | 0 | 0.00 |
| 2023-12-31 | 10.50 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.027B | $0.000B |
| Bellevue Life Sciences Acquisition Corp. is a blank check company. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. Bellevue Life Sciences Acquisition Corp. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.923B | 27.18 |
| CVS Health (CVS) | United States | $84.250B | 10.47 |
| Elevance Health (ELV) | United States | $79.134B | 10.21 |
| Cencora (COR) | United States | $56.436B | 19.63 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.062B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.762B | 17.65 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.704B | 0.00 |
| Solventum (SOLV) | United States | $13.538B | 14.33 |
| CochLear (CHEOY) | Australia | $12.960B | 0.00 |
| ICON (ICLR) | Ireland | $12.180B | 11.32 |
| Revvity (RVTY) | United States | $11.893B | 20.47 |
| Viatris (VTRS) | United States | $10.962B | 3.77 |
| Avantor (AVTR) | United States | $9.465B | 13.75 |
| Medpace Holdings (MEDP) | United States | $9.371B | 24.89 |
| HealthEquity (HQY) | United States | $8.758B | 38.36 |
| Sonic Healthcare (SKHHY) | Australia | $8.535B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.735B | 15.16 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.798B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.867B | 28.67 |
| BrightSpring Health Services (BTSG) | United States | $3.868B | 35.48 |
| Sotera Health (SHC) | United States | $3.304B | 18.77 |
| Surgery Partners (SGRY) | United States | $2.822B | 36.70 |
| Alignment Healthcare (ALHC) | United States | $2.693B | 0.00 |
| Concentras Parent (CON) | United States | $2.647B | 15.30 |
| Organon (OGN) | United States | $2.639B | 2.80 |
| GeneDx Holdings (WGS) | United States | $2.562B | 98.67 |
| PACS (PACS) | United States | $1.987B | 0.00 |
| Ardent Health (ARDT) | United States | $1.920B | 8.18 |
| Progyny (PGNY) | United States | $1.821B | 40.08 |
| GoodRx Holdings (GDRX) | United States | $1.805B | 36.11 |
| Premier (PINC) | United States | $1.789B | 13.58 |
| Teladoc Health (TDOC) | United States | $1.465B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.283B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.184B | 9.01 |
| CareDx (CDNA) | United States | $1.085B | 16.95 |
| Agilon Health (AGL) | United States | $0.989B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.843B | 7.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Nutex Health (NUTX) | United States | $0.679B | 10.28 |
| Embecta (EMBC) | United States | $0.599B | 4.04 |
| LifeMD (LFMD) | United States | $0.588B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.560B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.470B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| Omada Health (OMDA) | $0.466B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.463B | 0.00 |
| Enhabit (EHAB) | United States | $0.390B | 32.12 |
| So-Young (SY) | China | $0.338B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.316B | 0.00 |
| Beauty Health (SKIN) | United States | $0.266B | 0.00 |
| Oncology Institute (TOI) | United States | $0.218B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 26.17 |
| Pheton Holdings (PTHL) | China | $0.121B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.092B | 0.00 |
| KindlyMD (NAKA) | United States | $0.079B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |